A recent study by the US Department of Veterans Affairs has shed new light on the potential benefits of GLP-1 weight-loss drugs in treating various diseases and conditions. Published in the journal Nature Medicine, the study analyzed medical records from 2.5 million patients in the VA system and found links between these medications and reduced risks of Alzheimer’s disease and substance abuse.
The findings support existing suspicions about the effectiveness of these medications, with the analysis generating hypotheses rather than establishing causal relationships. Notably, the research suggests that GLP-1 weight-loss drugs may also be beneficial for patients struggling with alcohol, cannabis, or narcotics addiction.
Source: https://www.washingtonpost.com/health/2025/01/20/weight-loss-drugs-ozempic-wegovy-health-effects